Clinical trials play a crucial role in advancing medical research and bringing new and innovative treatments to the market. The Nordic region is known for its strong life science research
Nordic Life Science
NOT A SUBSCRIBER? SIGN UP TODAY AND GET THE FULL LIFE SCIENCE PICTURE
ONLY 13 €/MONTH
NLS News
The two companies are now supplying Ximluci (ranibizumab biosimilar) in England via a National Health Service (NHS) England Framework Agreement. The partners announced in January 2023 that the UK’s Medicines
Advertisement
On March 16, Peter Asplund’s report on clinical trials in Sweden was presented, containing proposals that should contribute to a long-term competitive and sustainable environment for clinical trials – with
The companies have signed a collaboration and distribution agreement that gives Thermo Fisher exclusive rights to commercialize, under combined brands, Devyser’s post-transplant portfolio of NGS products in North America and
The investors include several life science investors such as Life Science Invest Gamma, but also existing and new private investors. The raised capital will mainly be used for final product
Nykode Therapeutics has announced results from the VB-C-02 trial, investigating the use of Nykode’s therapeutic cancer vaccine candidate VB10.16 in combination with Roche’s cancer immunotherapy Tecentriq in patients with advanced
The issued patent covers the Dosage Manager device platform developed by OnDosis for dosing of oral solid medicines in the form of pellets. The issued patent is the first relating
The United States Patent and Trademark Office (USPTO) has granted the company’s patent application directed to gluconic acid derivatives for preventing and/or treating bacterial infections. “The US patent covering treatment
Genmab and argenx have entered into a collaboration agreement to jointly discover, develop and commercialize novel therapeutic antibodies with applications in immunology, as well as in oncology therapeutic areas. The
With this agreement, Perimed gains an additional sales channel as Lovell will notify the company of any government contract opportunities within its field of business and bid on Perimed’s behalf.
Aspect Biosystems and Novo Nordisk have announced a collaboration, development, and license agreement to develop bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions inside the body with
Ultimovacs has received a Notice of Intention to Grant from the European Patent Office (EPO) concerning its European Patent application on the use of vaccine-checkpoint inhibitor combinations to treat cancer.
The US Food and Drug Administration has accepted for review the company’s De Novo application for NAVOYÒ Sepsis, a clinical decision support software intended to assist healthcare providers at intensive
With lack of diversity and cross-border collaborations, we not only lose out on innovation – we jeopardize our democracy and risk losing an important driving force in promoting peace. In
Sponsored content
Perfecting solvent swap processes with refractive index trend data
Developing and optimizing pharmaceutical manufacturing processes can be a complex process. In order to streamline these processes and bring drugs to market faster, it is important for pharmaceutical companies to focus on creating efficient processes.
Learn more about how in-line process refractometers can optimize API processes!
Drug and Device Development
Heartseed has successfully dosed the first patient in a phase 1/2 clinical study (LAPiS Study) with HS-001 – an investigational cell therapy for heart failure. An independent safety evaluation committee
BioInvent International has announced that a fourth complete response has been observed in the 100 mg dose expansion cohort in the IV arm of the Phase 1/2 trial of its
Ultimovacs has adjusted guidance from the first half of 2023 to the second half of 2023 for communication of topline progression free survival (PFS) data from the INITIUM Phase II
SynAct Pharma has completed patient recruitment to the company’s clinical trial EXPAND which is evaluating its lead candidate compound AP1189 in early Rheumatoid Arthritis (RA) patients with severe disease activity.
Herantis Pharma has announced the dosing of the first healthy volunteer in the Phase 1a clinical study for HER-096. The Phase 1a clinical study will assess safety, tolerability, and blood-brain
Sponsored content
2023澳洲幸运5开奖查询 2023澳洲幸运5开奖历史记录 澳洲5历史记录官网 The challenges of temperature controlled logistics and how to overcome them
With more freight moving around the world than ever, combined with increased external circumstances causing supply chain disruptions, there’s never been such pressure on the success of temperature controlled logistics as there is now. NLS sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive goods and how to overcome them.
Profile
The philosophical aspect of chemistry led Morten Meldal to the field and he loves, and cannot help thinking about, the next solution and the intriguing questions about our being and
Iris Öhrn considers herself a cosmopolitan person, and with good reason. The investment advisor for life science at Business Region Göteborg left her native Cuba to study and work abroad
Massachusetts Institute of Technology (MIT) in the US has produced more than its share of engineers and computer scientists, but unlike many of his peers, alumnus Dr. Robert Langer, ScD,
Careers
Isa Lindgren has been intrigued by all things science since she was a child. As Manager of Analytical Development at NorthX Biologics she gets to integrate her fascination with a
SwedenBIO has appointed the co-founder and operational manager of Sprint Bioscience, Jessica Martinsson, as its new Director General. “With her entrepreneurial experience and co-founder of a life science company, SwedenBIO
Evaxion Biotech has announced that its new Chief Executive Officer (CEO) Per Norlén has joined the company on October 3rd. “With Per at the steering wheel, we expect to bring
Careers
In his job as Project Director at AstraZeneca’s Pharmaceutical Development unit, Anders Holmén constantly has to be one step ahead and has to be able to see how science best
JOB ALERTS
Read the latest issue of our magazine!
No 01 2023 // The major theme in this issue is Life Sciences for a Better World, highlighting both global and Nordic efforts being done within the fields of the Environment, Global health, Social responsibility and Peace. We take for example a closer look at the status of clinical trials in the Nordic region and the risks of APIs in the Baltic Sea region, we learn more about a company’s possibilities to increase its social impact and why academic freedom is so closely linked to democracy.
Our profiles in the issue are Nobel Laureate Carolyn Bertozzi, and Jónas Einarsson, CEO of Radforsk. They both share their inspiring journeys as well as their choices and passions in life.
This, and much more, in our latest issue – out now!
Venture Capital
Nordic Life Science asked Fredrik Dahl, co-founder at Colibri Ventures, what Nordic venture capitalists are looking for today within life sciences and what current opportunities and challenges Nordic life science
Nordic Life Science asked Claus Andersson, General Manager at Sunstone Life Science Venture, what Nordic venture capitalists are looking for today within life sciences and what current opportunities and challenges
Nordic Life Science asked Inka Mero, Founder and Managing Partner at Voima Ventures, what Nordic venture capitalists are looking for today within life sciences and what current opportunities and challenges
“Start by asking what the problem is that you are trying to solve and develop the technology, team, and plan to solve that problem – not what you can do with the technology.” – Fredrik Dahl, Colibri Ventures
Upcoming events
The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Innovative programming around the current and future
Focusing on core pharmaceutical packaging and drug delivery innovations. Connect in Pharma is the cost-effective market tool that aims to reach the epicentre of the pharma and biopharma industry. An
The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region. It has been connecting life science and healthcare industry leaders with international
Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world
The latest research news from the Nordic region
Science articles
The Royal Institute of Art and SciLifeLab have connected the creative minds of artists and scientists and the outcome of this fusion is explored in an exhibition at SciLifeLab campus.
Henrik Toft Sørensen, Professor of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, is receiving the 2023 prize, accompanied by 1.5 million DKK. He receives the Prize in recognition of
Findings from the major study iStopMM has been used to redefine monoclonal gammopathy of undetermined significance (MGUS), a precursor to multiple myeloma. We spoke with Þórir Einarsson Long, one of
An international team of researchers have combined ideas from biology, computer science and mathematics to explain why evolution seems to favor symmetry. We spoke with Iain Johnston, a professor at
Thanks to a donation of SEK 35 million from financier and philanthropist Rune Andersson, Karolinska Institutet’s research group leader Andrea Carmine Belin will very soon be setting up the world’s
Olink Holding has announced the 2022 winner of the young researchers’ award, Novelties in Biomarkers, Maria Martin-Grau at the University of Valencia, Spain. Novelties in Biomarkers is an annual award
Nordic Life Science
The latest clinical trials
BioInvent International has announced that a fourth complete response has been observed in the 100 mg dose expansion cohort in the IV arm of the Phase 1/2 trial of its
Ultimovacs has adjusted guidance from the first half of 2023 to the second half of 2023 for communication of topline progression free survival (PFS) data from the INITIUM Phase II
SynAct Pharma has completed patient recruitment to the company’s clinical trial EXPAND which is evaluating its lead candidate compound AP1189 in early Rheumatoid Arthritis (RA) patients with severe disease activity.
Herantis Pharma has announced the dosing of the first healthy volunteer in the Phase 1a clinical study for HER-096. The Phase 1a clinical study will assess safety, tolerability, and blood-brain
Nykode Therapeutics has announced results from the VB-C-02 trial, investigating the use of Nykode’s therapeutic cancer vaccine candidate VB10.16 in combination with Roche’s cancer immunotherapy Tecentriq in patients with advanced
Evaxion Biotech has announced preclinical data demonstrating the effectiveness of its AI-driven viral vaccine discovery platform. The presented preclinical study was conducted in collaboration with associate professor Girish Kirimanjeswara, Pennsylvania
Affibody have shared long-term 46-week data from a global Phase 2 trial of izokibep in psoriatic arthritis (PsA). The randomized double-blind, placebo-controlled, Phase 2 clinical trial evaluated the safety and
The company has presented data from two patients with liver metastases of colorectal cancer origin treated with ACT in the clinical Phase I ACTIVATE trial. The presented radiological results from
Affibody has announced that data from treatment with izokibep in the open label part (Part A) of a Phase 2b/3 trial in patients with moderate-to-severe Hidradenitis Suppurativa (HS) will be
Sign up to our newsletter